Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature339
Factors influencing COVID-19 vaccination intention among overseas and domestic Chinese university students: a cross-sectional survey286
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies171
Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic revi149
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study103
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria85
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial77
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States76
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities76
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam68
Correction65
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak63
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling62
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence60
Human vaccines & immunotherapeutics news: July 202058
Plasma therapy: a passive resistance against the deadliest58
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain57
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China57
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202157
Human vaccines & immunotherapeutics: News October 202257
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study56
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China55
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She54
Human vaccines & immunotherapeutics: news October 202154
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector50
HV&I Reviewer Highlight50
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons49
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control49
Improving Tdap maternal immunization rate in Saudi Arabia49
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals49
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines48
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children47
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy46
How to make effective HPV vaccine recommendations starting at age 946
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer45
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children45
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges44
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary43
Determinants of basic childhood vaccination coverage in European and OECD countries43
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study42
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study41
0.078810930252075